Furthermore, we determined the clinical relevance of the four candidate proteins and found that high RTN4IP1 or low NT5C expression predicted poor survival in patients with ESCC (Figure 1A; Figure S1C,D, Supporting Information). This evidence concerns the gene NT5C and esophageal squamous cell carcinoma.